A detailed history of American Century Companies Inc transactions in Illumina, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 203,514 shares of ILMN stock, worth $28.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
203,514
Previous 81,007 151.23%
Holding current value
$28.5 Million
Previous $8.46 Million 213.87%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$105.28 - $135.9 $12.9 Million - $16.6 Million
122,507 Added 151.23%
203,514 $26.5 Million
Q2 2024

Aug 07, 2024

SELL
$101.05 - $133.57 $2.48 Million - $3.28 Million
-24,544 Reduced 23.25%
81,007 $8.46 Million
Q1 2024

May 14, 2024

BUY
$127.73 - $147.2 $483,968 - $557,740
3,789 Added 3.72%
105,551 $14.5 Million
Q4 2023

Feb 13, 2024

BUY
$92.79 - $142.53 $9.44 Million - $14.5 Million
101,762 New
101,762 $14.2 Million
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $3.51 Million - $5.24 Million
-27,222 Reduced 25.9%
77,883 $10.7 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $611,555 - $775,721
-3,334 Reduced 3.07%
105,105 $19.7 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $5.38 Million - $6.46 Million
27,769 Added 34.42%
108,439 $25.2 Million
Q4 2022

Feb 13, 2023

SELL
$187.24 - $242.74 $812,059 - $1.05 Million
-4,337 Reduced 5.1%
80,670 $16.3 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $3.34 Million - $4.28 Million
-18,829 Reduced 18.13%
85,007 $16.2 Million
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $1.95 Million - $3.95 Million
-10,724 Reduced 9.36%
103,836 $19.1 Million
Q1 2022

May 11, 2022

BUY
$303.87 - $423.8 $149,807 - $208,933
493 Added 0.43%
114,560 $40 Million
Q4 2021

Feb 07, 2022

SELL
$347.28 - $421.83 $125,715 - $152,702
-362 Reduced 0.32%
114,067 $43.4 Million
Q3 2021

Nov 10, 2021

SELL
$405.61 - $524.84 $2.06 Million - $2.67 Million
-5,089 Reduced 4.26%
114,429 $46.4 Million
Q2 2021

Aug 05, 2021

SELL
$372.84 - $481.5 $1.96 Million - $2.53 Million
-5,255 Reduced 4.21%
119,518 $56.6 Million
Q1 2021

May 14, 2021

SELL
$361.28 - $504.76 $7.12 Million - $9.95 Million
-19,709 Reduced 13.64%
124,773 $47.9 Million
Q4 2020

Feb 12, 2021

SELL
$292.7 - $370.96 $284 Million - $360 Million
-971,218 Reduced 87.05%
144,482 $53.5 Million
Q3 2020

Nov 13, 2020

SELL
$268.51 - $400.74 $9.08 Million - $13.5 Million
-33,806 Reduced 2.94%
1,115,700 $345 Million
Q2 2020

Aug 13, 2020

BUY
$256.46 - $373.01 $2.49 Million - $3.62 Million
9,711 Added 0.85%
1,149,506 $426 Million
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $12.6 Million - $20.3 Million
60,414 Added 5.6%
1,139,795 $311 Million
Q4 2019

Feb 12, 2020

BUY
$288.29 - $335.49 $25.6 Million - $29.8 Million
88,782 Added 8.96%
1,079,381 $358 Million
Q3 2019

Nov 13, 2019

BUY
$266.84 - $378.23 $4.7 Million - $6.67 Million
17,631 Added 1.81%
990,599 $301 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $47.2 Million - $57.8 Million
157,093 Added 19.25%
972,968 $358 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $115 Million - $136 Million
421,953 Added 107.12%
815,875 $0
Q4 2018

Feb 13, 2019

SELL
$272.46 - $366.54 $14.3 Million - $19.2 Million
-52,381 Reduced 11.74%
393,922 $118 Million
Q3 2018

Nov 02, 2018

BUY
$279.04 - $367.06 $2.15 Million - $2.83 Million
7,707 Added 1.76%
446,303 $164 Million
Q2 2018

Aug 08, 2018

SELL
$228.17 - $292.07 $73.7 Million - $94.4 Million
-323,200 Reduced 42.43%
438,596 $122 Million
Q1 2018

May 03, 2018

BUY
$209.54 - $253.91 $25.7 Million - $31.1 Million
122,612 Added 19.18%
761,796 $180 Million
Q4 2017

Feb 02, 2018

BUY
$202.23 - $230.03 $6.88 Million - $7.83 Million
34,035 Added 5.62%
639,184 $140 Million
Q3 2017

Nov 01, 2017

BUY
$172.3 - $213.93 $104 Million - $129 Million
605,149
605,149 $121 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.